Investor Profile: Rev1 Ventures — Thesis, Cheque Size & How to Apply

Who Rev1 Ventures is

Rev1 Ventures is a Columbus, Ohio-based venture studio that combines seed capital with hands-on startup services. PitchBook describes it as a venture capital firm founded in 2013; the firm calls its model a venture studio, helping founders validate markets, build teams and become ready to raise.

Over the past decade, Rev1 Ventures says it has supported more than 1,400 startups, funded 150 unique companies, and generated $3.3 billion in economic impact in Columbus and more than $7 billion statewide. That regional depth is the point: Rev1 Ventures exists to make Central Ohio a place where technology companies can start and scale.

Thesis, sectors and stages

Rev1 Ventures invests at pre-seed and seed stage, with a focus on enterprise software, artificial intelligence, digital health and life sciences, fintech and insurtech, data analytics and alternative energy — rooted in the region's strengths: research from The Ohio State University, health systems such as Nationwide Children's Hospital, and Columbus's Fortune 1000 headquarters.

The studio model matters at the earliest stage: Rev1 Ventures offers advising, mentorship, workspace at Rev1 Labs and its Innovation Hub at The Peninsula, and connections to early customers, alongside capital — plus corporate partners that can open pilot routes cold outreach rarely achieves.

Fund size and cheque size

Rev1 Ventures invests through a series of named funds rather than one evergreen pool. Its first seed fund, Rev1 Fund I, was a $22 million fund. Its life sciences line includes the $15 million Rev1 Catalyst Fund II, backed by The Ohio State University, Nationwide Children's Hospital and Rev1 itself, and the $30 million Rev1 Catalyst Fund III launched in 2023. In 2024 it launched the $6 million Future Value Fund II for Central Ohio companies underserved by venture capital, with $3 million from Rev1 matched by Ohio's SSBCI programme.

Standard cheque sizes for current funds are not publicly disclosed. The firm's own reporting says its life sciences Fund I generated more than $250 million in exits, including the acquisitions of Celenex and Myonexus.

Notable portfolio

Rev1 Ventures portfolio companies include Updox and MentorcliQ, both of which continue to operate in Central Ohio, Champ Titles, a digital vehicle title platform that raised an $18 million Series C, HealthPlan Data Solutions, a pharmacy benefits cost-containment platform, Basking Biosciences, Deep Lens and Aware.

Partners and programmes

Tom Walker is president and chief executive of Rev1 Ventures and the public face of its regional mission. Its team works with partners including The Ohio State University and Nationwide Children's Hospital, which anchor its life sciences funds.

Its programmes centre on studio services, workspace at Rev1 Labs and the Innovation Hub at The Peninsula, and sector support through its Catalyst funds. There is no published perks catalogue; the value is services, space, mentorship and customer introductions.

How to apply for funding

Rev1 Ventures does not publish a single open application form with fixed deadlines. Founders typically start a conversation through the contact routes on rev1ventures.com, or by email at [email protected].

Come prepared with a clear account of the problem, the customer, and why Columbus's corporate and research network helps you specifically. Rev1 backs founders it can actively support, so show where you need help — customers, talent or follow-on capital. There is no published deadline; engagement is rolling.